Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Polyposis syndrome, hereditary mixed, 2, 610069 (Hereditary mixed polyposis syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hypohidrotic ectodermal dysplasia with immunodeficiency (sequence analysis of NFKBIA gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Molecular Genetics Laboratory North York General Hospital Canada | 10 | 18 |
|
Hereditary GI cancer panel (31 genes) Molecular Genetics Laboratory North York General Hospital Canada | 13 | 31 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
Centogene AG - the Rare Disease Company Germany | 27 | 29 |
|
Invitae Multi-Cancer + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 142 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 114 | 47 |
|
PreventionGenetics, part of Exact Sciences United States | 36 | 19 |
|
Ambry Genetics United States | 79 | 37 |
|
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States | 79 | 18 |
|
Ambry Genetics United States | 79 | 80 |
|
Congenital Diarrhea and Enteropathies Panel PreventionGenetics, part of Exact Sciences United States | 241 | 157 |
|
Variant Resolution Test for CancerNext® (+RNAinsight®) Ambry Genetics United States | 36 | 39 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 90 | 90 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.